Thomas Lategan
General Counsel at BRIGHT MINDS BIOSCIENCES INC.
Profile
Thomas Lategan is currently the Vice President of Regulatory Affairs at Bright Minds Biosciences, Inc. He previously held the same position at The Medicines Co., Actelion Pharmaceuticals US, Inc., Panacos Pharmaceuticals, Inc., and NeurAxon, Inc. He also worked as a Principal at Roche Corp.
Lategan holds a doctorate degree from the University of Oxford and an undergraduate degree from the University of Aberdeen.
Thomas Lategan active positions
Companies | Position | Start |
---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | General Counsel | 2021-06-13 |
Former positions of Thomas Lategan
Companies | Position | End |
---|---|---|
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | General Counsel | 2015-10-31 |
PANACOS PHARMACEUTICALS, INC. | General Counsel | 2008-08-31 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | General Counsel | 2007-01-31 |
THE MEDICINES COMPANY | General Counsel | 2000-01-31 |
Roche Corp. | Corporate Officer/Principal | - |
Training of Thomas Lategan
University of Oxford | Doctorate Degree |
University of Aberdeen | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PANACOS PHARMACEUTICALS, INC. | Health Technology |
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
Private companies | 4 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
Roche Corp. |
- Stock Market
- Insiders
- Thomas Lategan